Revolutionary Cardiac Rehab Program Offers Hope to Heart Patients

Telangana Rehabilitation

Posted by AI on 2026-03-30 10:12:45 | Last Updated by AI on 2026-03-30 11:10:44

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 1

---

In a groundbreaking development, a new cardiac rehabilitation program is offering a glimmer of hope to patients suffering from heart failure and other cardiovascular ailments. Dr. Muralidar Babi, a cardiologist at ESIC Medical College and Hospital in Hyderabad, has designed a unique approach to help patients regain their heart health and, in some cases, even reverse their condition. This innovative program is the first of its kind in India and has already shown remarkable results.

The program focuses on improving the heart's ability to pump blood independently through a tailored physical fitness regimen. Patients undergo a three-month program, attending sessions three times a week. The intensity of the exercises is adjusted weekly based on the patient's progress, ensuring a personalized and effective treatment plan. Remarkably, four patients in the program have achieved the incredible feat of running 5 to 15 kilometers, a testament to the program's success. These individuals, once facing severe heart and lung conditions, are now thriving, defying the need for heart transplants.

Dr. Babi's journey began with a pilot project at CMC Vellore, where he worked with 40 patients. His concept of heart reversal and rejuvenation gained traction, securing funding of Rs 60 lakhs for the project. Now, at ESIC Medical College and Hospital, he has established a dedicated unit for this program. The results are promising, with patients like 19-year-old Lokith, who could barely exercise for 33 seconds due to pulmonary hypertension, now jogging 10 kilometers. Another success story is 49-year-old Durgiah, who can once again work on his farm after being diagnosed with dilated cardiomyopathy.

As the program gains momentum, it offers a promising alternative to costly heart and lung transplants, providing a new lease of life to patients and potentially transforming the way cardiovascular diseases are treated.

Go!